We're Transforming Medicine Systems To
Impact Change For Generations
Through research, education, and partnerships,
I-MAK is committed to finding solutions to address structural inequity in the medicines system.
See the latest in news from I-MAK experts
For press inquiries, please contact simon@i-mak.org
February 24, 2023
Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
January 25, 2023
Patent reform and lower drug prices should be bipartisan priorities
February 26, 2023
Big Pharma fights patent disclosure demand from investors
March 26, 2023
The Next Pandemic with Priti Krishtel and Tahir Amin
July 3, 2023
I-MAK’s Quest To Trim The Biopharmaceutical Patent Thicket
December 4, 2022
How AbbVie denied Americans access to fair competition for Humira
November 7, 2022
Life-Changing Drug Costs Over $3,000 in US, $0 to $225 in Europe
April 16, 2022
Save America’s Patent System
September 15, 2022
Gaming of U.S. Patent System Is Keeping Drug Prices Sky High
September 16, 2022
Consumer group says drugmakers abuse U.S. patent system to keep prices high
Report pulls no punches in critique of drug patent abuse
Health Affairs
March 23, 2022
Addressing Drug Patent Abuse: Restoring The Role Of Inter Partes Review
Learn more about how you can help build a more equitable system for all